top of page
Search Results

387 items found for "Bing Li"

  • 📰 GPCR Weekly News, August 21 to 27, 2023

    mechanisms and therapeutic targets in atopic diseases Methods & Updates in GPCR Research TrGPCR:GPCR-ligand Binding Affinity Predicting based on Dynamic Deep Transfer Learning Reviews, GPCRs, and more Key Aspects water-soluble QTY variants Structural basis for the allosteric modulation of rhodopsin by nanobody binding NEW February 3 - 7, 2024 | SLAS2024 International Conference and Exhibition NEW March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar NEW March 24 - 29, 2024 | Ligand Recognition and Molecular

  • β-arrestin1 and 2 exhibit distinct phosphorylation-dependent conformations when coupling to the...

    β-arrestin1 and 2 exhibit distinct phosphorylation-dependent conformations when coupling to the same GPCR in living However, whether β-arrestin1 and 2 respond differently for binding to the same GPCR is still unknown.

  • Unlocking the Future of Medicine: Advancements in GPCR Research

    Application of this knowledge to determine the mechanism of action of new GPCR ligands. New ligands and new GPCR behaviors that produce unique drug profiles (i.e., intracellular ligands and Hosted by the Adhesion GPCR Consortium, this exciting event will occur in lively and culturally rich maintains muscle stem cell quiescence and prevents stem cell loss Activation of Polycystin-1 Signaling by Binding from a Marine Cyanobacterium Fluorophore-Labeled Pyrrolones Targeting the Intracellular Allosteric Binding

  • 📰 GPCR Weekly News, September 4 to 10, 2023

    Serotonin signaling regulates actomyosin contractility during morphogenesis in evolutionarily divergent lineages Immunology [1,2,4]Triazolo[1,5-c]pyrimidines as Tools to Investigate A3 Adenosine Receptors in Cancer Cell Lines Molecular Insights into GPCR Function Structure and Molecular Mechanism of Signaling for the Glucagon-like Meeting February 3 - 7, 2024 | SLAS2024 International Conference and Exhibition March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating

  • 📰 GPCR Weekly News, August 28 to September 3, 2023

    retinopathy GPCR Binders, Drugs, and more The Leu/Val6.51 Side Chain of Cannabinoid Receptors Regulates the Binding antagonist using an X-ray free-electron laser Structural insight into the selective agonist ST1936 binding Meeting February 3 - 7, 2024 | SLAS2024 International Conference and Exhibition March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating

  • A new Kunitz-type snake toxin family associated with an original mode of interaction with the...

    MQs were produced by solid-phase peptide synthesis and characterized in vitro by binding and functional The number of MQ1 residues involved in V2R binding is large and may explain its absolute selectivity.

  • Structural basis for receptor selectivity and inverse agonism in S1P5 receptors

    The structure demonstrates a unique ligand-binding mode, involving an allosteric sub-pocket, which clarifies structures in complex with antagonists and agonists, our structure with S1P5-inverse agonist sheds light

  • Mechanistic Understanding of the Palmitoylation of Go Protein in the Allosteric Regulation of...

    analyses indicated that the palmitoylation of Go can allosterically stabilize the critical residues in the ligand-binding pocket of GPR97 and increase the affinity of the ligand for GPR97.

  • 📰 GPCR Weekly News, April 22 to 28, 2024

    Hoare's workshop for individuals who live and work in developing countries.  mapping G-protein-coupled receptor agonists Development of a synthetic relaxin-3/INSL5 chimeric peptide ligand for NanoBiT complementation binding assays Generation of a deep mouse brain spectral library for transmembrane Structural and Molecular Insights into GPCR Function Fungal alkaloid malbrancheamide reorients the lipid A GPCRs Industry News Introducing Big Sky BacMam Chemical tool illuminates pathways used by dopamine

  • Nuclear localization of histamine receptor 2 in primary human lymphatic endothelial cells

    In the presence of its ligand, we show significant upregulation of H2R nuclear translocation kinetics Using fluorescently tagged histamine, we explored H2R-histamine binding interaction, which exhibits a In this aspect, our present data shed new light on the unexplored H2R signaling mechanisms.

  • Mechanistic basis of GPCR activation explored by ensemble refinement of crystallographic structures

    Here, ensemble refinement (ER) of crystallographic structures is applied to explore the impact of binding

  • Novel interaction between neurotrophic factor-α1/carboxypeptidase E and serotonin receptor, 5-HTR1E,

    Co-immunoprecipitation and pull-down assays confirmed interaction between NFα1/CPE and 5-HTR1E and 125I NF-α1/CPE-binding studies demonstrated saturable, high-affinity binding to 5-HTR1E in stably transfected HEK293 cells

  • 📰 GPCR Weekly News, February 12 to 18, 2024

    You can still join this waitlist and be the first to know when the live course is offered later this You'll share your contributor articles with the community, stay updated with GPCR literature, join a Drugs, and more Nanobody-Mediated Dualsteric Engagement of the Angiotensin Receptor Broadens Biased Ligand binding GPCRs in Oncology and Immunology Neutrophils are itching to specialize A GPCR-neuropeptide axis Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating

  • 📰 GPCR Weekly News, January 22 to 28, 2024

    Margarita Stampelou, Graham Ladds, and Antonios Kolocouris refine AlphaFold models using binding calculations Take 2 minutes to fill out this survey and let us know what you liked, what you didn’t, and what we can analysis of Gi-coupling receptors via engineered Gt and Nb35 application Imaging GPCR Dimerization in Living in Pharmacology and Drug Discovery March 13 - 15 | 9th German Pharm-Tox Summit March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating

  • 📰 GPCR Weekly News, January 15 to 21, 2024

    Graham Ladds’ team refines AlphaFold models using binding calculations for human adenosine A3 receptor If you'd like to join colleagues and Dr. The cost is USD $299 and includes: Four live Zoom sessions (1 hour lecture + 30 mins Q&A each) A 30-minute News Novartis Lutathera® significantly reduced risk of disease progression or death by 72% as first-line Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating

  • Precise druggability of the PTH type 1 receptor

    GPCRs) are notoriously difficult to target by small molecules because their large orthosteric peptide-binding pocket embedded deep within the transmembrane domain limits the identification and development of nonpeptide small molecule ligands.

  • 📰 GPCR Weekly News, December 11 to 17, 2023

    Ross Cheloha's research involves semi-synthetic nanobody-ligand conjugates with enhanced transcriptional GPCR University's live Zoom sessions hosted by Dr. Terry Kenakin. The cost is $299 and includes: All 4 live Zoom sessions ( 4x 1 hour lecture + 30 mins Q&A) Complementary functional GPCRs tANCHOR fast and cost-effective cell-based immunization approach with focus on the receptor-binding into GPCR Function Using AlphaFold and Experimental Structures for the Prediction of the Structure and Binding

  • Network pharmacological investigation into the mechanism of Kaixinsan powder for the treatment of...

    highlighted the most significant pathways associated with depression treatment, including neuroactive ligand-receptor molecular docking results showed that Polygalaxanthone III, Girinimbine and Pachymic acid performed greater binding targets (5-HTR, DR, ADRA, AR, ESR, NR3C1) and modulate the activation of multiple pathways (Neuroactive ligand

  • 📰 GPCR Weekly News, February 20 to 26, 2023

    If you'd like to suggest papers to include in our news, please email them to us at Hello@DrGPCR.com. Impact of membrane lipid polyunsaturation on dopamine D2 receptor ligand binding and signaling GPCR Binders Application of computational methods for class A GPCR Ligand discovery. Gαi-derived peptide binds the µ-opioid receptor. (May 22 - 26, 2023) 2nd LEAPS Meets Life Sciences Conference.

  • GPCRs steer G i and G s selectivity via TM5-TM6 switches as revealed by structures of serotonin...

    of Gs versus Gi protein coupling selectivity or promiscuity by class A GPCRs and extend the basis of ligand

  • Characterization of a new WHIM syndrome mutant reveals mechanistic differences in regulation of ...

    is at least partially due to a significant decrease in agonist-promoted phosphorylation, β-arrestin binding syndrome mutant, CXCR4-S339fs5, that promotes enhanced signaling, reduced phosphorylation, β-arrestin binding

  • Biphasic activation of β-arrestin 1 upon interaction with a GPCR revealed by methyl-TROSY NMR

    The conformation-selective antibody, Fab30, promotes partially activated βarr into the activated-like This plasticity of βarr conformation in complex with GPCRs engaged in different binding modes may explain

  • Dynamic recognition of naloxone, morphine and endomorphin1 in the same pocket of µ-opioid receptors

    metadynamics-enhanced conformational sampling are used here to determine the different interactions of these two ligands The endogenous peptide ligand endomorphin-1 (EM-1) underwent almost no significant conformational changes agonist of MOR, and I322A also significantly attenuated the potency of MOR on EM-1, confirming that binding This finding reveals a dynamic mechanism for the response of MOR to different ligands and provides a basis for the discovery of new ligands for MOR at the atomic level."

  • N-terminal alterations turn the gut hormone GLP-2 into an antagonist with gradual loss of GLP-2 ...

    COS-7 cells were transfected with the human GLP-2R and assessed for cAMP accumulation or competition binding

  • Identification of A2BAR as a potential target in colorectal cancer using novel fluorescent GPCR...

    2022 Identification of A2BAR as a potential target in colorectal cancer using novel fluorescent GPCR ligands We selected the adenosine receptor 2B (A2BAR), specifically expressed in cancer cell lines compared with stromal cells, to explore the use of fluorescent ligands that can be used for target visualization. expression of A2BAR in CRC cell lines. As well, fluorescent ligands were effective at monitoring real-time A2BAR receptor labeling using live-imaging

  • In vitro assays for the functional characterization of (psychedelic) substances at the serotonin...

    In particular, focus lies on the mechanism behind the techniques, and the specific advantages and challenges that one should consider when attempting to compare functional outcomes from different studies, both linked to the specific assay mechanism and linked to its specific execution, as these may heavily impact the

  • Divergent roles for the gut intraepithelial lymphocyte GLP-1R in control of metabolism, microbiota..

    cell-induced inflammation "Gut intraepithelial lymphocytes (IELs) are thought to calibrate glucagon-like peptide 1 (GLP-1) bioavailability, thereby regulating systemic glucose and lipid metabolism. -1RAs require the gut IEL GLP-1R to selectively restrain local and systemic T cell-induced, but not lipopolysaccharide-induced Such effects are mediated by the suppression of gut IEL effector functions linked to the dampening of These data reposition key roles of the L cell-gut IEL GLP-1R axis, revealing mechanisms linking GLP-1R

  • C5aR2 receptor: The genomic twin of the flamboyant C5aR1

    September 2022 "The complement fragment C5a is one of the most potent proinflammatory glycoproteins liberated C5a is established to interact with a set of genomically related transmembrane receptors, like C5aR1 structure of C5aR2 and its interaction specificity toward C5a is not structurally elucidated in the literature

bottom of page